By Smitha Mundasad – BBC.
The Cancer Drugs Fund will continue to pay for the breast cancer treatment Kadcyla, after the company Roche cut its price, the NHS in England has said.
The fund, which pays for drugs not routinely available on the NHS, has been cutting the number it offers, in order to balance the books.
Many, including breast cancer treatment Avastin, remain off the fund’s list, as treatments for certain tumours.
Charities say the fund is worryingly unstable and causes patients anxiety…read the full article.
